Youngy End Period Cash Flow from 2010 to 2025

300247 Stock   3.58  0.09  2.45%   
Youngy Health's End Period Cash Flow is decreasing over the years with slightly volatile fluctuation. Overall, End Period Cash Flow is expected to go to about 140.2 M this year. From 2010 to 2025 Youngy Health End Period Cash Flow quarterly data regression line had arithmetic mean of  244,460,592 and r-squared of  0.78. View All Fundamentals
 
End Period Cash Flow  
First Reported
2019-09-30
Previous Quarter
209.5 M
Current Value
207.6 M
Quarterly Volatility
53.5 M
 
Covid
Check Youngy Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Youngy Health's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 82.8 M or Total Revenue of 521.5 M, as well as many indicators such as . Youngy financial statements analysis is a perfect complement when working with Youngy Health Valuation or Volatility modules.
  
This module can also supplement various Youngy Health Technical models . Check out the analysis of Youngy Health Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Youngy Stock

Youngy Health financial ratios help investors to determine whether Youngy Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Youngy with respect to the benefits of owning Youngy Health security.